CytoAgents, Inc., a clinical-stage biotechnology company developing CTO1681, a novel, steroid sparing inhibitor of prostaglandin mediated inflammation, announced today that preliminary safety data ...

In 2021, when planning her first trip to the US, Indira Zhainakova had no intention of starting a business there, let ...

Daredevil: Born Again star Jon Bernthal has revealed new insights into how Spider-Man: Brand New Day and The Punisher Special ...

Foresight Diagnostics, a leader in ultrasensitive minimal residual disease (MRD) detection technology, today announced the presentation of multiple lymphoma studies featuring Foresight CLARITY™ ...

Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported 3Q:25 results, confirming the pre-new drug application (NDA) meeting with the FDA in 4Q:25 to see if an NDA can be accepted using existing ...

Just like QVC lets entrepreneurs show off and sell their products, social media can let side hustling creators show off their ...

Scientific posters are often the first release of clinical data to the medical community. REVEAL is an end-to-end tailored platform that revolutionises the way scientific posters are created, enhanced ...

Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...

Supergirl director Craig Gillespie told us about a promise James Gunn made to him regarding the DCU. Fortunately, Gunn kept ...

Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.

Accelerating an Anthracycline-Free Future: A New Drug in Clinical Testing Offers Patients Hope for Safer, More Effective Breast Cancer Therapy Combinations Date: Thursday, December 11, 2025 Time: 5 p.

SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., will present new data on cenobamate, an ...